Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Effect of cimetidine on survival after gastric cancer

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Colorectal Cancer in Individuals With Familial Adenomatous Polyposis, Based on Analysis of the Danish Polyposis Registry

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. A proposed staging system and stage-specific interventions for familial adenomatous polyposis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Local involvement of the lower urinary tract in primary colorectal cancer - outcome after en-bloc resection

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Transanal endoscopic microsurgery for giant polyps of the rectum

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. The outcome of rectal cancer after early salvage TME following TEM compared with primary TME: a case-matched study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

The effect of cimetidine on survival was investigated in 181 patients with gastric cancer. Immediately after operation or the decision not to operate, the patients were randomised in double-blind fashion to placebo or cimetidine 400 mg twice daily for two years or until death, with review every three months. Median survival in the cimetidine group was 450 days (range 1-1826) and in the placebo group 316 days (1-1653). The relative survival rates (cimetidine/placebo) were 45%/28% at 1 year, 22%/13% at 2 years, 13%/7% at 3 years, 9%/3% at 4 years, and 2%/0% at 5 years. Survival in the cimetidine group was significantly longer than in the placebo group.

OriginalsprogEngelsk
TidsskriftLancet
Vol/bind2
Udgave nummer8618
Sider (fra-til)990-992
Antal sider3
ISSN0140-6736
StatusUdgivet - 29 okt. 1988

ID: 32522129